Tumor Ablation Therapy Devices Global Market Report 2024

Description

“Tumor Ablation Therapy Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor ablation therapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor ablation therapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The tumor ablation therapy devices market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Technology: Radiofrequency Ablation; Microwave Ablation; Cryoablation; Irreversible Electroporation Ablation; Other Technologies
2) By Treatment: Surgical; Laparoscopic; Percutaneous
3) By Application: Kidney Cancer; Liver Cancer; Breast Cancer; Lung Cancer; Prostate Cancer; Other Applications
4) By End User: Hospitals; Oncology Clinics; Other End Users
Companies Mentioned: Galil Medical Inc.; Misonix Inc.; HealthTronics Inc.; AngioDynamics Inc.; Boston Scientific Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Tumor ablation therapy devices are medical instruments that are minimally invasive and are employed in the treatment of tumors, most commonly those located in the kidney, liver, and lung.

The primary technologies utilized in tumor ablation therapy devices include radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other related methods. Irreversible electroporation (IRE) is an innovative technique within tumor ablation therapy, involving the application of micro to millisecond electrical pulses to undesired tissue, which results in the induction of cell necrosis through irreversible cell membrane permeabilization. Treatments using these devices can take the form of surgical procedures, laparoscopic interventions, or percutaneous methods, and are applicable in the treatment of various types of cancer, including kidney, liver, breast, lung, prostate, and others. The end-users of tumor ablation therapy devices encompass hospitals, oncology clinics, and other healthcare facilities.

The tumor ablation therapy devices market research report is one of a series of new reports from The Business Research Company that provides tumor ablation therapy devices market statistics, including tumor ablation therapy devices industry global market size, regional shares, competitors with a tumor ablation therapy devices market share, detailed tumor ablation therapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor ablation therapy devices industry. This tumor ablation therapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor ablation therapy devices market size has grown rapidly in recent years. It will grow from $0.64 billion in 2023 to $0.74 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth observed during the historical period can be attributed to several key factors, including the increasing incidence of cancer, notable technological advancements in the field, a growing aging population, and the popularity of minimally invasive medical procedures for tumor treatment.

The tumor ablation therapy devices market size is expected to see rapid growth in the next few years. It will grow to $1.27 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The anticipated growth in the forecast period can be attributed to various factors, including the adoption of personalized medicine, the development of combination therapies, the integration of artificial intelligence (AI) and image-guided ablation techniques, the increasing utilization of telemedicine and remote consultations, and a focus on training and education within the healthcare sector. Significant trends expected in the forecast period encompass ongoing advancements in ablation technologies, improvements in imaging guidance, the incorporation of robotic and navigation assistance, the integration of immuno-oncology treatments, and the expanding use of percutaneous and image-guided ablation procedures.

The tumor ablation therapy devices market is experiencing growth driven by the increasing prevalence of cancer. Cancer is a leading cause of mortality, with approximately 1 in 6 deaths worldwide attributed to this disease. Tumor ablation therapy is a minimally invasive procedure widely used to treat various types of tumors, including those in the lung, liver, kidney, and bones. For example, in 2023, the American Cancer Society Inc., a US-based non-profit health organization, estimates that the US will see around 1,958,310 new cancer cases, an increase compared to the more than 1,918,030 new cancer cases in 2022. This procedure offers an effective treatment option, particularly for patients who have not responded to chemotherapy or radiotherapy, thus supporting the growth of the tumor ablation therapy devices market.

The rising demand for minimally invasive procedures is expected to propel the tumor ablation therapy devices market. Minimally invasive procedures involve specialized instruments and technology to minimize incisions, leading to less disruption to the patient's body. Tumor ablation therapy devices play a crucial role in these procedures by effectively destroying tumors while minimizing damage to surrounding tissues. For instance, in January 2023, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that approximately 1,875,000 surgical procedures were performed using da Vinci surgical systems in 2022, marking an 18% increase from the roughly 1,594,000 procedures conducted in 2021. Therefore, the growing demand for minimally invasive procedures is expected to drive the tumor ablation therapy devices market's growth.

Major companies in the tumor ablation therapy devices market are focusing on technological advancements to improve procedure efficiency, safety, reduce radiation exposure, shorten learning curves, and enhance patient outcomes. For instance, Compal Electronics, a Taiwan-based electronics manufacturing company, introduced AblatePal in April 2023, a new radiofrequency ablation (RFA) system designed for the percutaneous, intraoperative coagulation and ablation of soft tissue, particularly non-resectable liver lesions. It employs electrical resistance to generate heat energy in the targeted tissue, resulting in its eradication. This system has applications in therapeutic medical devices, especially for cancer treatment.

Major companies are committed to developing minimally invasive therapies to gain a competitive edge in the market. Minimally invasive therapy is highly effective for tumor ablation, providing precise treatment with minimal disruption to surrounding tissues. For example, in August 2023, Francis Medical Inc., a US-based provider of minimally invasive treatment solutions for prostate, kidney, and bladder cancer, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Vanquish minimally invasive water vapor ablation therapy. This designation aims to expedite the device's development and regulatory evaluation, potentially ensuring quicker patient access. The Vanquish system employs sterile water's thermal energy for precise cancer tissue treatment through a straightforward transurethral procedure, minimizing the risk of severe side effects associated with alternative prostate cancer therapies.

In August 2022, Imagin Medical, a Canada-based urologic oncology company, acquired the enCAGE Coil Precision Ablation System for Prostate Cancer from TROD Medical NV for $2.5 million. This acquisition strengthens Imagin's position as a urologic oncology company and broadens its portfolio in the field of prostate cancer. TROD Medical NV is a Belgium-based medical device company.

Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic PLC, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew PLC, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation

North America was the largest region in the tumor ablation therapy devices market in 2023. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor ablation therapy devices market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The tumor ablation therapy devices market consists of sales of radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others that are used for tumor ablation therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r9258

1. Executive Summary

2. Tumor Ablation Therapy Devices Market Characteristics

3. Tumor Ablation Therapy Devices Market Trends And Strategies

4. Tumor Ablation Therapy Devices Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Tumor Ablation Therapy Devices Market Size and Growth

5.1. Global Tumor Ablation Therapy Devices Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Tumor Ablation Therapy Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Tumor Ablation Therapy Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Tumor Ablation Therapy Devices Market Segmentation

6.1. Global Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Other Technologies
6.2. Global Tumor Ablation Therapy Devices Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Surgical
Laparoscopic
Percutaneous
6.3. Global Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Kidney Cancer
Liver Cancer
Breast Cancer
Lung Cancer
Prostate Cancer
Other Applications
6.4. Global Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Oncology Clinics
Other End Users

7. Tumor Ablation Therapy Devices Market Regional And Country Analysis

7.1. Global Tumor Ablation Therapy Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Tumor Ablation Therapy Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Tumor Ablation Therapy Devices Market

8.1. Asia-Pacific Tumor Ablation Therapy Devices Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Tumor Ablation Therapy Devices Market

9.1. China Tumor Ablation Therapy Devices Market Overview
9.2. China Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Tumor Ablation Therapy Devices Market

10.1. India Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Tumor Ablation Therapy Devices Market

11.1. Japan Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Tumor Ablation Therapy Devices Market

12.1. Australia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Tumor Ablation Therapy Devices Market

13.1. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Tumor Ablation Therapy Devices Market

14.1. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Tumor Ablation Therapy Devices Market

15.1. Western Europe Tumor Ablation Therapy Devices Market Overview
15.2. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Tumor Ablation Therapy Devices Market

16.1. UK Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Tumor Ablation Therapy Devices Market

17.1. Germany Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Tumor Ablation Therapy Devices Market

18.5. France Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Tumor Ablation Therapy Devices Market

19.9. Italy Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Tumor Ablation Therapy Devices Market

20.13. Spain Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Tumor Ablation Therapy Devices Market

21.1. Eastern Europe Tumor Ablation Therapy Devices Market Overview
21.2. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Tumor Ablation Therapy Devices Market

22.1. Russia Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Tumor Ablation Therapy Devices Market

23.1. North America Tumor Ablation Therapy Devices Market Overview
23.2. North America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Tumor Ablation Therapy Devices Market

24.1. USA Tumor Ablation Therapy Devices Market Overview
24.2. USA Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Tumor Ablation Therapy Devices Market

25.1. Canada Tumor Ablation Therapy Devices Market Overview
25.2. Canada Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Tumor Ablation Therapy Devices Market

26.1. South America Tumor Ablation Therapy Devices Market Overview
26.2. South America Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Tumor Ablation Therapy Devices Market

27.1. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Tumor Ablation Therapy Devices Market

28.1. Middle East Tumor Ablation Therapy Devices Market Overview
28.2. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Tumor Ablation Therapy Devices Market

29.1. Africa Tumor Ablation Therapy Devices Market Overview
29.2. Africa Tumor Ablation Therapy Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Tumor Ablation Therapy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Tumor Ablation Therapy Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Tumor Ablation Therapy Devices Market Competitive Landscape And Company Profiles

30.1. Tumor Ablation Therapy Devices Market Competitive Landscape
30.2. Tumor Ablation Therapy Devices Market Company Profiles
- 30.2.1. Galil Medical Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Misonix Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. HealthTronics Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. AngioDynamics Inc
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Boston Scientific Corporation
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Tumor Ablation Therapy Devices Market Competitive Benchmarking

32. Global Tumor Ablation Therapy Devices Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Tumor Ablation Therapy Devices Market

34. Tumor Ablation Therapy Devices Market Future Outlook and Potential Analysis

34.1 Tumor Ablation Therapy Devices Market In 2028 - Countries Offering Most New Opportunities
34.2 Tumor Ablation Therapy Devices Market In 2028 - Segments Offering Most New Opportunities
34.3 Tumor Ablation Therapy Devices Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer